Physician profile
Peter B Frechie
NPI 1568465524
$13,252.95
in general payments reported to CMS, 2019-2025
42 companies · $3,688 in 2025
The $3,688 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,979 · 2020: $469 · 2021: $755 · 2022: $1,289 · 2023: $1,669 · 2024: $2,403 · 2025: $3,688.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,250 · Travel and Lodging: $1,510.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,250.23 |
| Travel and Lodging | $1,510.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,505.08 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Novartis Pharmaceuticals Corporation | $1,205.93 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,088.07 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $861.68 | 2019-2024 | Lux-Dx Insertable Cardiac Monitor, Watchman Access System |
| Edwards Lifesciences Corporation | $842.12 | 2019-2025 | Pascal, Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $832.58 | 2019-2025 | Camzyos, Eliquis |
| Astrazeneca Pharmaceuticals LP | $718.38 | 2019-2025 | Farxiga, Wainua, Brilinta |
| Pfizer INC. | $633.77 | 2019-2025 | |
| Amgen INC. | $621.39 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $514.09 | 2019-2025 | Navitor, Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems |
| Abiomed | $437.93 | 2021-2023 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $395.64 | 2019-2025 | Lifevest |
| Lexicon Pharmaceuticals, INC. | $315.54 | 2023-2024 | Inpefa |
| Merck Sharp & Dohme LLC | $312.37 | 2022-2025 | Verquvo |
| Medtronic Vascular, INC. | $264.65 | 2019-2020 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $198.26 | 2019-2025 | Jardiance |
| Cordis US Corp. | $186.19 | 2022-2024 | Brite Tip Radianz, Mynx Venous Vcd, Mynx Control |
| Alnylam Pharmaceuticals INC. | $129.21 | 2025 | Onpattro |
| Atricure, INC. | $110.97 | 2024-2025 | Synergy Ablation System, Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax |
| Kiniksa Pharmaceuticals, LTD. | $103.78 | 2022-2023 | Arcalyst |
| Kestra Medical Technology Services, INC. | $96.86 | 2023-2024 | Assure Wcd |
| Actelion Pharmaceuticals US, INC. | $96.42 | 2023-2024 | Opsumit, Uptravi |
| Ekos Corporation | $93.15 | 2019 | |
| Sanofi-Aventis U.S. LLC | $88.49 | 2019-2023 | |
| Ge Healthcare | $74.60 | 2025 | |
| Novo Nordisk INC | $74.55 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Shockwave Medical, INC | $64.50 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Esperion Therapeutics, INC. | $63.22 | 2023-2025 | Nexletol |
| Biosense Webster, INC. | $41.64 | 2023 | Octaray Mapping Catheter, Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $35.00 | 2024 | Arcalyst |
| Endotronix, INC. | $30.11 | 2024 | Cordella Pulomonary Artery Pressure Sensor |
| Astellas Pharma US INC | $29.37 | 2019-2022 | |
| Daiichi Sankyo INC. | $28.76 | 2023 | Injectafer |
| Teleflex LLC | $24.59 | 2025 | Vascband |
| Ethicon US, LLC | $22.30 | 2023 | Prolene, Ethicon |
| Regeneron Healthcare Solutions, INC. | $19.05 | 2025 | Evkeeza |
| Althera Pharmaceuticals LLC | $17.62 | 2021 | |
| Inspire Medical Systems, INC. | $16.55 | 2024 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $16.54 | 2025 | |
| Amarin Pharma, INC. | $14.23 | 2019 | |
| Medicomp INC | $14.14 | 2024 | Telepatch Cardiac Monitor |
| Terumo Medical Corporation | $13.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Frechie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.